Morepen Laboratories logo

Morepen Laboratories share news, announcements and annual reports

NSE: MOREPENLABBSE: 500288Pharmaceuticals & BiotechnologySmall Cap

Morepen Laboratories Limited · Face value ₹2 · Listed Mar 1993 on BSE, Nov 1999 on NSE
Last close ₹113.35down ₹5.96 (5.00%)BSE ₹113.70

Share price at the NSE close on 30 Oct 2026. Previous close ₹119.31.

30 Oct: open ₹113.35, high ₹122.23, low ₹113.35

52-week range of traded prices to 30 Oct 2026
₹33.05Low, 30 Mar 2026₹150.70High, 7 Oct 2026
Market cap
₹6,211 Cr1,108th largest listed
P/E
32.94
P/B
4.50
Dividend yield
0.18%
ROE
14.6%
ROCE
14.3%
Debt to equity
0.22
Volume, NSE
88,57,838

Morepen Laboratories results

70 filed, newest first. Page 2 of 2.

  1. Feb 2015

  2. Nov 2014

  3. Aug 2014

  4. May 2014

  5. Feb 2014

  6. Nov 2013

  7. Aug 2013

  8. May 2013

  9. Feb 2013

  10. Nov 2012

  11. Aug 2012

  12. May 2012

  13. Feb 2012

  14. Nov 2011

  15. Aug 2011

  16. May 2011

  17. Feb 2011

  18. Apr 2010

    • 30 Apr · Results

      Company has decided to submit audited financial results for the entire financial year within 60 days of the end of the financial year instead to submit un-audited financial results along with the limited review report within 45 days.
  19. Apr 2009

    • 21 Apr · Results

      Company has proposed to file Audited Accounts for the last quarter ended on March 31, 2009. And therefore instead of Un audited Accounts, with Limited Review Report, the Company will provide Audited Accounts for the year along with the Audit Statement for the last quarter, within 3 months of the end of the financial year, as per the listing agreement i.e. by June 30, 2009.
  20. Apr 2008

    • 23 Apr · Results

      We shall be submitting and publishing the audited annual financial results within a period of 3 months from the close of the financial year ending as on March 31, 2008.